Insider Stock Trading History of Swiftcurrent Offshore Ltd


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Swiftcurrent Offshore Ltd since year 2005. The trader's CIK number is 1124973. At the time of this reporting, Swiftcurrent Offshore Ltd is the 10% Owner of Response Genetics Inc . (stock ticker symbol RGDX). See this page for all insider trading activities at Response Genetics Inc .

Note that in the past SWIFTCURRENT OFFSHORE LTD also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Swiftcurrent Offshore Ltd since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2012-09-13 RGDX Response Genetics Inc Buy 3,000,000 1.10 3,300,000
2009-10-08 TRMS Trimeris Inc Sale 2,136,858 3.53 7,551,656
2008-12-12 ORCH Orchid Biosciences Inc Buy 915,110 .65 594,821
2008-04-14 JAZZ Jazz Pharmaceuticals Inc Buy 9,940 8.47 84,191
2008-04-11 JAZZ Jazz Pharmaceuticals Inc Buy 10,724 8.45 90,617
2008-04-10 JAZZ Jazz Pharmaceuticals Inc Buy 2,461 8.50 20,918
2008-04-08 JAZZ Jazz Pharmaceuticals Inc Buy 300 8.48 2,544
2008-04-07 JAZZ Jazz Pharmaceuticals Inc Buy 26,847 8.66 232,495
2008-04-04 JAZZ Jazz Pharmaceuticals Inc Buy 1,500 8.74 13,110
2008-04-03 JAZZ Jazz Pharmaceuticals Inc Buy 7,449 8.75 65,178
2008-04-03 JAZZ Jazz Pharmaceuticals Inc Buy 7,449 8.75 65,178
2008-04-03 JAZZ Jazz Pharmaceuticals Inc Buy 7,449 8.75 65,178
2008-04-02 JAZZ Jazz Pharmaceuticals Inc Buy 40,779 8.74 356,408
2008-03-14 JAZZ Jazz Pharmaceuticals Inc Buy 1 9.48 9
2008-03-14 JAZZ Jazz Pharmaceuticals Inc Buy 1 9.48 9

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Swiftcurrent Offshore Ltd (10% Owner of Response Genetics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.